Delivery Order SPE2DR25D3003-SPE2DR26F5QA2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,817.41 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.13 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price delivery order with no set-aside designation, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitively awarded transaction under AmerisourceBergen's existing federal contract portfolio...
- The Defense Logistics Agency awarded a $7,203.58 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for MIEBO 100% eye drops (3ML). This is a firm fixed-price, competitively awarded contract with a completion date of July 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a $7,011.60 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $14,193.62 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order carries no set-aside designation and reflects a competitive award to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,098.64 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML, with an ultimate completion date of November 3, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QA2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,655.19 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop medication in 3ML units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems globally. The company's extensive federal contract portfolio demonstrates its established capability to meet DLA requirements across multiple therapeutic domains, positioning it as a key vendor for military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 11/18/25 |